The tragic death of a sixth-form pupil in Oxfordshire from meningitis has sparked calls for a wider rollout of vaccines in the UK. Lewis Waters, who recently passed away, is part of a concerning trend, as two other students are currently being treated for the disease. The charity Meningitis Now is advocating for the inclusion of the Meningitis B (MenB) vaccine in the routine immunisation schedule for teenagers and young adults, which is currently not available on the NHS.
Dr Tom Nutt, chief executive of Meningitis Now, highlighted that while the MenB vaccine is effective, its high cost is a barrier to its wider use. The UK Health Security Agency (UKHSA) has confirmed one case of MenB among the affected students and is monitoring the situation closely. The agency reassured the public that the risk remains low, but the recent cases underline the need for vigilance regarding this serious illness.
For UK residents, this situation serves as a reminder to ensure vaccinations are up to date, particularly for young people. The MenACWY vaccine is still available for free on the NHS for those under 25, but it does not cover all strains of meningitis, including MenB. Parents and guardians should be proactive in discussing vaccination options with healthcare providers to protect their children.
Looking ahead, the Joint Committee on Vaccination and Immunisation (JCVI) is currently reviewing the eligibility for MenB vaccinations. The outcome of this review could significantly impact public health policy and vaccination strategies in the UK. Keeping an eye on the JCVI’s recommendations will be crucial for families and healthcare professionals alike.
Sources
BBC News
